Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Citations to this article

Efferocytosis produces a prometastatic landscape during postpartum mammary gland involution
Jamie C. Stanford, … , H. Shelton Earp III, Rebecca S. Cook
Jamie C. Stanford, … , H. Shelton Earp III, Rebecca S. Cook
Published September 24, 2014
Citation Information: J Clin Invest. 2014;124(11):4737-4752. https://doi.org/10.1172/JCI76375.
View: Text | PDF
Research Article Oncology Article has an altmetric score of 37

Efferocytosis produces a prometastatic landscape during postpartum mammary gland involution

  • Text
  • PDF
Abstract

Breast cancers that occur in women 2–5 years postpartum are more frequently diagnosed at metastatic stages and correlate with poorer outcomes compared with breast cancers diagnosed in young, premenopausal women. The molecular mechanisms underlying the malignant severity associated with postpartum breast cancers (ppBCs) are unclear but relate to stromal wound-healing events during postpartum involution, a dynamic process characterized by widespread cell death in milk-producing mammary epithelial cells (MECs). Using both spontaneous and allografted mammary tumors in fully immune–competent mice, we discovered that postpartum involution increases mammary tumor metastasis. Cell death was widespread, not only occurring in MECs but also in tumor epithelium. Dying tumor cells were cleared through receptor tyrosine kinase MerTK–dependent efferocytosis, which robustly induced the transcription of genes encoding wound-healing cytokines, including IL-4, IL-10, IL-13, and TGF-β. Animals lacking MerTK and animals treated with a MerTK inhibitor exhibited impaired efferocytosis in postpartum tumors, a reduction of M2-like macrophages but no change in total macrophage levels, decreased TGF-β expression, and a reduction of postpartum tumor metastasis that was similar to the metastasis frequencies observed in nulliparous mice. Moreover, TGF-β blockade reduced postpartum tumor metastasis. These data suggest that widespread cell death during postpartum involution triggers efferocytosis-induced wound-healing cytokines in the tumor microenvironment that promote metastatic tumor progression.

Authors

Jamie C. Stanford, Christian Young, Donna Hicks, Philip Owens, Andrew Williams, David B. Vaught, Meghan M. Morrison, Jiyeon Lim, Michelle Williams, Dana M. Brantley-Sieders, Justin M. Balko, Debra Tonetti, H. Shelton Earp III, Rebecca S. Cook

×

Total citations by year

Year: 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 Total
Citations: 3 10 9 11 3 15 7 14 8 9 6 1 96
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal. Not all publishers participate in CrossRef, so this information is not comprehensive. Additionally, data may not reflect the most current citations to this article, and the data may differ from citation information available from other sources (for example, Google Scholar, Web of Science, and Scopus).

Citations to this article (96)

Title and authors Publication Year
Efferocytosis: The Janus‐Faced Gatekeeper of Aging and Tumor Fate
Liu Z, Li Y, Ren Y, Chen J, Weng S, Zhou Z, Luo P, Chen Q, Xu H, Ba Y, Zuo A, Liu S, Zhang Y, Pan T, Han X
Aging Cell 2025
Proteolysis of TAM receptors in autoimmune diseases and cancer: what does it say to us?
Malikova I, Worth A, Aliyeva D, Khassenova M, Kriajevska MV, Tulchinsky E
Cell Death & Disease 2025
Reproductive state controls transcription in the murine liver, with implications for breast cancer liver metastasis
Ozaki MK, Zhang Y, Bartlett AQ, de Wilde E, Guan X, Yang A, Xia Z, Schedin P
Proceedings of the National Academy of Sciences of the United States of America 2025
A Bispecific Modeling Framework Enables the Prediction of Efficacy, Toxicity, and Optimal Molecular Design of Bispecific Antibodies Targeting MerTK.
Li R, Dere E, Kwong M, Fei M, Dave R, Masih S, Wang J, McNamara E, Huang H, Liang WC, Schutt L, Kamath AV, Ovacik MA
The AAPS Journal 2024
Inhibition of MER proto-oncogene tyrosine kinase by an antisense oligonucleotide enhances treatment efficacy of immunoradiotherapy.
Hu Y, Revenko A, Barsoumian H, Bertolet G, Fowlkes NW, Maazi H, Green MM, He K, Sezen D, Voss TA, Leyton CSK, Masrorpour F, Rafiq Z, Puebla-Osorio N, Leuschner C, MacLeod R, Cortez MA, Welsh JW
Journal of experimental & clinical cancer research : CR 2024
Regulation of Mertk Surface Expression via ADAM17 and γ-Secretase Proteolytic Processing
Lahey KC, Varsanyi C, Wang Z, Aquib A, Gadiyar V, Rodrigues AA, Pulica R, Desind S, Davra V, Calianese DC, Liu D, Cho JH, Kotenko SV, De Lorenzo MS, Birge RB
International journal of molecular sciences 2024
Progress of research on the relationship between efferocytosis and tumor
Yao X, Zhang L, Sun S, Fu A, Ge Y
Frontiers in Oncology 2024
Efferocytosis by macrophages in physiological and pathological conditions: regulatory pathways and molecular mechanisms
Sheng Y, Hu W, Chen S, Zhu X
Frontiers in immunology 2024
In the Eyes of the Beholder—New Mertk Knockout Mouse and Re-Evaluation of Phagocytosis versus Anti-Inflammatory Functions of MERTK
Ghosh S, Finnemann SC, Vollrath D, Rothlin CV
International journal of molecular sciences 2024
Osteopontin regulation of MerTK+ macrophages promotes Crohn’s disease intestinal fibrosis
Liu J, Gong W, Liu P, Li Y, Jiang H, Wu C, Wu X, Zhao Y, Ren J
iScience 2024
CD9 and Aryl Hydrocarbon Receptor Are Markers of Human CD19+CD14+ Atypical B Cells and Are Dysregulated in Systemic Lupus Erythematous Disease.
Blevins LK, Khan DMIO, Crawford RB, O'Neill C, Bach AP, Zhou J, Karmaus PW, Ang DC, Thapa R, Kaminski NE
Journal of immunology (Baltimore, Md. : 1950) 2024
MERTK inhibition selectively activates a DC - T-cell axis to provide anti-leukemia immunity.
Huelse JM, Bhasin SS, Jacobsen KM, Yim J, Thomas BE, Branella GM, Bakhtiari M, Chimenti ML, Baxter TA, Raikar SS, Wang X, Frye SV, Henry CJ, Earp HS, Bhasin M, DeRyckere D, Graham DK
Leukemia 2024
Phosphatidylserine externalization as immune checkpoint in cancer.
Kur IM, Weigert A
Pflugers Archiv : European journal of physiology 2024
Control of tumor-associated macrophage responses by nutrient acquisition and metabolism.
Zhang X, Ji L, Li MO
Immunity 2023
Inhibiting efferocytosis reverses macrophage-mediated immunosuppression in the leukemia microenvironment
Cruz Cruz J, Allison KC, Page LS, Jenkins AJ, Wang X, Earp HS, Frye SV, Graham DK, Verneris MR, Lee-Sherick AB
Frontiers in immunology 2023
Cell death, therapeutics, and the immune response in cancer
Hänggi K, Ruffell B
Trends in Cancer 2023
Integration of Single-Cell RNA Sequencing and Bulk RNA Sequencing Reveals That TAM2-Driven Genes Affect Immunotherapeutic Response and Prognosis in Pancreatic Cancer.
Du Y, Dong S, Jiang W, Li M, Li W, Li X, Zhou W
International journal of molecular sciences 2023
Targeting MerTK decreases efferocytosis and increases anti-tumor immune infiltrate in prostate cancer.
Myers Chen KV, de Groot AE, Mendez SA, Mallin MM, Amend SR, Pienta KJ
Medical Oncology 2023
TAM family kinases as therapeutic targets at the interface of cancer and immunity.
DeRyckere D, Huelse JM, Earp HS, Graham DK
Nature reviews. Clinical oncology 2023
Interface between Resolvins and Efferocytosis in Health and Disease.
Mohammad-Rafiei F, Negahdari S, Tahershamsi Z, Gheibihayat SM
Cell Biochemistry and Biophysics 2023
The Prognosis of Cancer Depends on the Interplay of Autophagy, Apoptosis, and Anoikis within the Tumor Microenvironment.
Gulia S, Chandra P, Das A
Cell Biochemistry and Biophysics 2023
Hijacking homeostasis: Regulation of the tumor microenvironment by apoptosis
Gregory CD
Immunological Reviews 2023
The role of phosphatidylserine on the membrane in immunity and blood coagulation
J Wang, C Yu, J Zhuang, W Qi, J Jiang, X Liu, W Zhao, Y Cao, H Wu, J Qi, R Zhao
Biomarker Research 2022
MerTK-mediated efferocytosis promotes immune tolerance and tumor progression in osteosarcoma through enhancing M2 polarization and PD-L1 expression
J Lin, A Xu, J Jin, M Zhang, J Lou, C Qian, J Zhu, Y Wang, Z Yang, X Li, W Yu, B Liu, H Tao
OncoImmunology 2022
The Apoptosis Paradox in Cancer
O Morana, W Wood, C Gregory
International journal of molecular sciences 2022
Phosphatidylserine released from apoptotic cells in tumor induces M2‐like macrophage polarization through the PSR‐STAT3‐JMJD3 axis
X Liang, M Luo, B Shao, J Yang, A Tong, R Wang, Y Liu, R Jun, T Liu, T Yi, X Zhao, Y Wei, X Wei
2022
The immune environment of the mammary gland fluctuates during post-lactational regression and correlates with tumour growth rate
Hitchcock J, Hughes K, Pensa S, Lloyd-Lewis B, Watson CJ
Development (Cambridge, England) 2022
Which Has a Greater Impact on the Recurrence in Young Breast Cancer Patients: Recent Childbirth or Recent Breastfeeding?
Yan C, Bai J, Bao S, Xia Y, Yu H, Yin Y
The Breast Journal 2022
BMS794833 inhibits macrophage efferocytosis by directly binding to MERTK and inhibiting its activity.
Bae SH, Kim JH, Park TH, Lee K, Lee BI, Jang H
Experimental & molecular medicine 2022
Tissue-specific modifier alleles determine Mertk loss-of-function traits.
Akalu YT, Mercau ME, Ansems M, Hughes LD, Nevin J, Alberto EJ, Liu XN, He LZ, Alvarado D, Keler T, Kong Y, Philbrick WM, Bosenberg M, Finnemann SC, Iavarone A, Lasorella A, Rothlin CV, Ghosh S
eLife 2022
Efferocytosis drives myeloid NLRP3 dependent inflammasome signaling secretion of IL-1β to promote tumor growth
Lang C, Roy S, Wang Y, Graves D, Xu Y, Serezani CH, Korrer M, Kim YJ
Frontiers in immunology 2022
Bone Marrow Macrophages Induce Inflammation by Efferocytosis of Apoptotic Prostate Cancer Cells via HIF-1α Stabilization
Mendoza-Reinoso V, Schnepp PM, Baek DY, Rubin JR, Schipani E, Keller ET, McCauley LK, Roca H
Cells 2022
Metabolic disorders sensitise endometrial carcinoma through endoplasmic reticulum stress.
Zhou J, Lin Y, Yang X, Shen B, Hao J, Wang J, Wang J
Cellular & Molecular Biology Letters 2022
Dual targeting of TAM receptors Tyro3, Axl, and MerTK: Role in tumors and the tumor immune microenvironment
KH Wang, DC Ding
Tzu Chi Medical Journal 2021
Postpartum breast cancer has a distinct molecular profile that predicts poor outcomes
S Jindal, ND Pennock, D Sun, W Horton, MK Ozaki, J Narasimhan, AQ Bartlett, S Weinmann, PE Goss, VF Borges, Z Xia, P Schedin
Nature Communications 2021
Reprograming of Tumor-Associated Macrophages in Breast Tumor-Bearing Mice under Chemotherapy by Targeting Heme Oxygenase-1
SH Kim, SJ Kim, J Park, Y Joe, SE Lee, S Saeidi, X Zhong, SH Kim, SA Park, HK Na, HT Chung, YJ Surh
Antioxidants 2021
Unique Pro-Inflammatory Response of Macrophages during Apoptotic Cancer Cell Clearance
V Mendoza-Reinoso, DY Baek, A Kurutz, JR Rubin, AJ Koh, LK McCauley, H Roca
Cells 2020
Lifting the innate immune barriers to antitumor immunity
CV Rothlin, S Ghosh
Journal for ImmunoTherapy of Cancer 2020
The role of phosphatidylserine recognition receptors in multiple biological functions
MB Naeini, V Bianconi, M Pirro, A Sahebkar
Cellular & Molecular Biology Letters 2020
Measurement and models accounting for cell death capture hidden variation in compound response
SY Bae, N Guan, R Yan, K Warner, SD Taylor, AS Meyer
Cell Death and Disease 2020
Small Molecule Soluble Epoxide Hydrolase Inhibitors in Multitarget and Combination Therapies for Inflammation and Cancer
AD Mahapatra, R Choubey, B Datta
Molecules (Basel, Switzerland) 2020
LC3-Associated Phagocytosis (LAP): A Potentially Influential Mediator of Efferocytosis-Related Tumor Progression and Aggressiveness
PF Asare, E Roscioli, PR Hurtado, HB Tran, CY Mah, S Hodge
Frontiers in Oncology 2020
Expression of TAM-R in Human Immune Cells and Unique Regulatory Function of MerTK in IL-10 Production by Tolerogenic DC
P Giroud, S Renaudineau, L Gudefin, A Calcei, T Menguy, C Rozan, J Mizrahi, C Caux, V Duong, J Valladeau-Guilemond
Frontiers in immunology 2020
Cell Death in the Tumor Microenvironment: Implications for Cancer Immunotherapy
V Gadiyar, KC Lahey, D Calianese, C Devoe, D Mehta, K Bono, S Desind, V Davra, RB Birge
Cells 2020
A Potent and Selective Dual Inhibitor of AXL and MERTK Possesses Both Immunomodulatory and Tumor-Targeted Activity
J Rios-Doria, M Favata, K Lasky, P Feldman, Y Lo, G Yang, C Stevens, X Wen, S Sehra, K Katiyar, K Liu, R Wynn, JJ Harris, M Ye, S Spitz, X Wang, C He, YL Li, W Yao, M Covington, P Scherle, H Koblish
Frontiers in Oncology 2020
Efferocytosis and Its Associated Cytokines: A Light on Non-tumor and Tumor Diseases?
D Lin, X Kang, L Shen, S Tu, C Lenahan, Y Chen, X Wang, A Shao
Molecular Therapy — Oncolytics 2020
Cancer Cells and M2 Macrophages: Cooperative Invasive Ecosystem Engineers
KV Myers, KJ Pienta, SR Amend
Cancer control : journal of the Moffitt Cancer Center 2020
Efficient blockade of locally reciprocated tumor-macrophage signaling using a TAM-avid nanotherapy
SJ Wang, R Li, TS Ng, G Luthria, MJ Oudin, M Prytyskach, RH Kohler, R Weissleder, DA Lauffenburger, MA Miller
Science Advances 2020
Macrophage morphology correlates with single-cell diversity and prognosis in colorectal liver metastasis
M Donadon, G Torzilli, N Cortese, C Soldani, LD Tommaso, B Franceschini, R Carriero, M Barbagallo, A Rigamonti, A Anselmo, FS Colombo, G Maggi, A Lleo, J Cibella, C Peano, P Kunderfranco, M Roncalli, A Mantovani, F Marchesi
Journal of Experimental Medicine 2020
Neuropilin-2b facilitates resistance to tyrosine kinase inhibitors in non-small cell lung cancer.
Dimou A, Nasarre C, Peterson YK, Pagano R, Gooz M, Nasarre P, Drabkin HA, Armeson KE, Gibney BC, Gemmill RM, Denlinger CE
The Journal of Thoracic and Cardiovascular Surgery 2020
MERTK in Cancer Therapy: Targeting the Receptor Tyrosine Kinase in Tumor Cells and the Immune System
Huelse J, Fridlyand D, Earp S, DeRyckere D, Graham DK
Pharmacology & Therapeutics 2020
Living on the Edge: Efferocytosis at the Interface of Homeostasis and Pathology
S Morioka, C Maueröder, KS Ravichandran
Immunity 2019

Blocking TGF-β Signaling To Enhance The Efficacy Of Immune Checkpoint Inhibitor


X Bai, M Yi, Y Jiao, Q Chu, K Wu
OncoTargets and therapy 2019
Targeting Tyro3, Axl and MerTK (TAM receptors): implications for macrophages in the tumor microenvironment
KV Myers, SR Amend, KJ Pienta
Molecular Cancer 2019
MERTK tyrosine kinase receptor together with TIM4 phosphatidylserine receptor mediates distinct signal transduction pathways for efferocytosis and cell proliferation
C Nishi, Y Yanagihashi, K Segawa, S Nagata
The Journal of biological chemistry 2019
Gas6/MerTK signaling is negatively regulated by NF-κB and supports lung carcinogenesis
SV Novitskiy, R Zaynagetdinov, G Vasiukov, S Gutor, W Han, A Serezani, A Matafonov, LA Gleaves, TP Sherrill, VV Polosukhin, TS Blackwell
Oncotarget 2019
Suppression of chemotherapy-induced cytokine/lipid mediator surge and ovarian cancer by a dual COX-2/sEH inhibitor
A Gartung, J Yang, VP Sukhatme, DR Bielenberg, D Fernandes, J Chang, BA Schmidt, SH Hwang, D Zurakowski, S Huang, MW Kieran, BD Hammock, D Panigrahy
Proceedings of the National Academy of Sciences 2019
Therapeutic inhibition of Mcl-1 blocks cell survival in estrogen receptor-positive breast cancers.
Williams MM, Elion DL, Rahman B, Hicks DJ, Sanchez V, Cook RS
Oncotarget 2019
MERTK inhibition alters the PD-1 axis and promotes anti-leukemia immunity
Alisa Lee Sherick, Kristen M Jacobsen, Curtis Henry, Madeline G Huey, Rebecca E. Parker, Lauren Page, Amanda A Hill, Xiaodong Wang, Stephen Frye, Shelton Earp, Craig T. Jordan, Deborah DeRyckere, Douglas K. Graham
JCI Insight 2018
Tumor-Secreted Pros1 Inhibits Macrophage M1 Polarization to Reduce Anti-Tumor Immune Response
Eric Ubil, Laura Caskey, Alisha Holtzhausen, Debra Hunter, Charlotte Story, Shelton Earp
Journal of Clinical Investigation 2018
Macrophage-Derived Neuropilin-2 Exhibits Novel Tumor-Promoting Functions
S Roy, AK Bag, S Dutta, NS Polavaram, R Islam, S Schellenburg, J Banwait, C Guda, S Ran, MA Hollingsworth, RK Singh, JE Talmadge, MH Muders, SK Batra, K Datta
Cancer research 2018
Repeated exposure of epithelial cells to apoptotic cells induces the specific selection of an adaptive phenotype: Implications for tumorigenesis
L Feng, S Vujicic, ME Dietrich, N Litbarg, S Setty, A Antoni, J Rauch, JS Levine
The Journal of biological chemistry 2018
Exploitation of Apoptotic Regulation in Cancer
DS Ucker, JS Levine
Frontiers in immunology 2018
Chemotherapy-generated cell debris stimulates colon carcinoma tumor growth via osteopontin
J Chang, SS Bhasin, DR Bielenberg, VP Sukhatme, M Bhasin, S Huang, MW Kieran, D Panigrahy
The FASEB Journal 2018
Ibuprofen supports macrophage differentiation, T cell recruitment, and tumor suppression in a model of postpartum breast cancer
ND Pennock, HA Martinson, Q Guo, CB Betts, S Jindal, T Tsujikawa, LM Coussens, VF Borges, P Schedin
Journal for ImmunoTherapy of Cancer 2018
Targeting tumour microenvironment by tyrosine kinase inhibitor
HY Tan, N Wang, W Lam, W Guo, Y Feng, YC Cheng
Molecular Cancer 2018
Efferocytosis in the tumor microenvironment
TA Werfel, RS Cook
Seminars in Immunopathology 2018
The Mammary Microenvironment in Mastitis in Humans, Dairy Ruminants, Rabbits and Rodents: A One Health Focus
K Hughes, CJ Watson
Journal of Mammary Gland Biology and Neoplasia 2018
The Multifaceted Role of STAT3 in Mammary Gland Involution and Breast Cancer
K Hughes, C Watson
International journal of molecular sciences 2018
Impaired efferocytosis by monocytes in multiple myeloma
Y Liang, I Schwarzinger, I SimonitschKlupp, H Agis, R Oehler
Oncology Letters 2018
Autophagy and unfolded protein response (UPR) regulate mammary gland involution by restraining apoptosis-driven irreversible changes
A Wärri, KL Cook, R Hu, L Jin, A Zwart, DR Soto-Pantoja, J Liu, T Finkel, R Clarke
Cell Death Discovery 2018
Efferocytosis and prostate cancer skeletal metastasis: implications for intervention.
Roca H, McCauley LK
Oncoscience 2018
Apoptosis-induced CXCL5 accelerates inflammation and growth of prostate tumor metastases in bone
Hernan Roca, Jacqueline Jones, Marta Purica, Savannah Weidner, Amy Koh, Robert Kuo, John Wilkinson, Yugang Wang, Stephanie Daignault, Kenneth Pienta, Todd Morgan, Evan Keller, Jacques Nor, Lonnie Shea, Laurie mccauley
Journal of Clinical Investigation 2017
S1P Provokes Tumor Lymphangiogenesis via Macrophage-Derived Mediators Such as IL-1 β or Lipocalin-2
SN Syed, M Jung, A Weigert, B Brüne
Mediators of Inflammation 2017
TAM receptor tyrosine kinases as emerging targets of innate immune checkpoint blockade for cancer therapy
YT Akalu, CV Rothlin, S Ghosh
Immunological Reviews 2017
Mammary Gland Involution Provides a Unique Model to Study the TGF-β Cancer Paradox
Q Guo, C Betts, N Pennock, E Mitchell, P Schedin
Journal of Clinical Medicine 2017
Iron Handling in Tumor-Associated Macrophages—Is There a New Role for Lipocalin-2?
M Jung, A Weigert, C Mertens, C Rehwald, B Brüne
Frontiers in immunology 2017
Editorial: How Reproductive History Influences Our Breast Cancer Risk
RL Anderson, WV Ingman, KL Britt
Frontiers in Oncology 2017
Antagonistic Coevolution of MER Tyrosine Kinase Expression and Function
AL Evans, JW Blackburn, K Taruc, A Kipp, BS Dirk, NR Hunt, SD Barr, JD Dikeakos, B Heit
Molecular Biology and Evolution 2017
MUC1 induces M2 type macrophage influx during postpartum mammary gland involution and triggers breast cancer
Y Li, Z Pang, X Dong, X Liao, H Deng, C Liao, Y Liao, G Chen, L Huang
Oncotarget 2017
Phosphatidylserine is a global immunosuppressive signal in efferocytosis, infectious disease, and cancer
RB Birge, S Boeltz, S Kumar, J Carlson, J Wanderley, D Calianese, M Barcinski, RA Brekken, X Huang, JT Hutchins, B Freimark, C Empig, J Mercer, AJ Schroit, G Schett, M Herrmann
Cell Death and Differentiation 2016
Deciphering Pro-Lymphangiogenic Programs during Mammary Involution and Postpartum Breast Cancer
VF Borges, AM Elder, TR Lyons
Frontiers in Oncology 2016
A fate worse than death: apoptosis as an oncogenic process
G Ichim, SW Tait
Nature Reviews Cancer 2016
Rab17 mediates differential antigen sorting following efferocytosis and phagocytosis
C Yin, Y Kim, D Argintaru, B Heit
Cell Death and Disease 2016
Myeloid-Epithelial-Reproductive Receptor Tyrosine Kinase and Milk Fat Globule Epidermal Growth Factor 8 Coordinately Improve Remodeling After Myocardial Infarction via Local Delivery of Vascular Endothelial Growth FactorCLINICAL PERSPECTIVE
KY Howangyin, I Zlatanova, C Pinto, A Ngkelo, C Cochain, M Rouanet, J Vilar, M Lemitre, C Stockmann, BK Fleischmann, Z Mallat, JS Silvestre
Circulation 2016
The Dynamics of Apoptotic Cell Clearance
MR Elliott, KS Ravichandran
Developmental Cell 2016
Ligand Activation of TAM Family Receptors-Implications for Tumor Biology and Therapeutic Response
V Davra, S Kimani, D Calianese, R Birge
Cancers 2016
Efferocytosis in oral squamous cell carcinoma
GS Sarode
Journal of Oral and Maxillofacial Pathology : JOMFP 2016
Non-Canonical Cell Death Induced by p53
A Ranjan, T Iwakuma
International journal of molecular sciences 2016
Oncogenic Properties of Apoptotic Tumor Cells in Aggressive B Cell Lymphoma
CA Ford, S Petrova, JD Pound, JJ Voss, L Melville, M Paterson, SL Farnworth, AM Gallimore, S Cuff, H Wheadon, E Dobbin, CA Ogden, IE Dumitriu, DR Dunbar, PG Murray, D Ruckerl, JE Allen, DA Hume, N van Rooijen, JR Goodlad, TC Freeman, CD Gregory
Current Biology 2015
ICAM-1 suppresses tumor metastasis by inhibiting macrophage M2 polarization through blockade of efferocytosis
M Yang, J Liu, C Piao, J Shao, J Du
Cell Death and Disease 2015
Discovering Molecules That Regulate Efferocytosis Using Primary Human Macrophages and High Content Imaging
S Santulli-Marotto, A Gervais, J Fisher, B Strake, CA Ogden, C Riveley, J Giles-Komar, N Palaniyar
PloS one 2015
Mammary epithelial cell phagocytosis downstream of TGF-β3 is characterized by adherens junction reorganization
J Fornetti, KC Flanders, PM Henson, AC Tan, VF Borges, P Schedin
Cell Death and Differentiation 2015
Clearance of dying cells accelerates malignancy
DB Vaught, RS Cook
Oncotarget 2015
Efferocytosis creates a tumor microenvironment supportive of tumor survival and metastasis.
Vaught DB, Stanford JC, Cook RS
Cancer Cell & Microenvironment 2015
The TAM family: phosphatidylserine-sensing receptor tyrosine kinases gone awry in cancer
DK Graham, D DeRyckere, KD Davies, HS Earp
Nature Reviews Cancer 2014

← Previous 1 2 3 4 Next →

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts

Picked up by 3 news outlets
Blogged by 1
Posted by 2 X users
Referenced in 3 patents
Mentioned by 1 weibo users
108 readers on Mendeley
See more details